VolitionRx Limited Finance Lease, Principal Payments
VolitionRx Limited (VNRX) reported Finance Lease, Principal Payments of $46.51 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2024-03-25
- VolitionRx Limited finance lease, principal payments for the quarter ending 2023-06-30 was $11.74K, a 4.37% increase year-over-year.
- VolitionRx Limited finance lease, principal payments for the quarter ending 2023-03-31 was $11.45K, a 12.85% decline year-over-year.
- VolitionRx Limited finance lease, principal payments for the quarter ending 2022-06-30 was $11.25K.
- VolitionRx Limited finance lease, principal payments for the quarter ending 2022-03-31 was $13.13K.
- VolitionRx Limited finance lease, principal payments for fiscal 2023 was $46.51K, a 2.36% increase from fiscal 2022.
- VolitionRx Limited finance lease, principal payments for fiscal 2022 was $45.43K, a 21.95% decline from fiscal 2021.
- VolitionRx Limited finance lease, principal payments for fiscal 2021 was $58.21K, a 40.25% decline from fiscal 2020.
- VolitionRx Limited finance lease, principal payments for fiscal 2020 was $97.42K.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|
| 2023-12-31 | $46.51K 10-K · filed 2024-03-25 | ||
| 2023-06-30 | $11.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $23.19K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $11.45K 10-Q · filed 2023-05-10 | ||
| 2022-12-31 | $45.43K 10-K · filed 2024-03-25 | ||
| 2022-06-30 | $11.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $24.38K 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $13.13K 10-Q · filed 2023-05-10 | ||
| 2021-12-31 | $58.21K 10-K · filed 2022-03-30 | ||
| 2020-12-31 | $97.42K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |